Jeremy Bridge-Cook

President & Chief Executive Officer at RNA Diagnostics, Inc.

Jeremy Bridge-Cook

Jeremy Bridge-Cook

President & Chief Executive Officer at RNA Diagnostics, Inc.

Overview
Career Highlights

RNA Diagnostics, Inc.

RelSci Relationships

207

Number of Boards

2

Birthday

1969

Age

50

Contact Data
Trying to get in touch with Jeremy Bridge-Cook? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Jeremy Bridge-Cook likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer at RNA Diagnostics, Inc.

Relationship likelihood: Strong

Executive Vice President Corporate Development at RNA Diagnostics, Inc.

Relationship likelihood: Strong

Chief Advisor at Relentless Pursuit Partners, Inc.

Relationship likelihood: Strong

Chief Operating Officer & Director at Steinberg Global Asset Management Ltd.

Relationship likelihood: Strong

Director at RNA Diagnostics, Inc.

Relationship likelihood: Strong

Director at Ontario Genomics Institute (Private Equity)

Relationship likelihood: Strong

Co-Founder at Genesys Capital Partners, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at RNA Diagnostics, Inc.

Relationship likelihood: Strong

President & Chief Scientific Officer at Translatum Medicus, Inc.

Relationship likelihood: Strong

Partner at PricewaterhouseCoopers LLP

Relationship likelihood: Strong

Paths to Jeremy Bridge-Cook
Potential Connections via
Relationship Science
You
Jeremy Bridge-Cook
President & Chief Executive Officer at RNA Diagnostics, Inc.
Education
Ph.D. in Immunology
Class of 1997

Established in 1827, the University of Toronto has one of the strongest research and teaching faculties in North America, presenting top students at all levels with an intellectual environment unmatched in depth and breadth on any other Canadian campus. With more than 82,000* students across three campuses (St. George, Mississauga and Scarborough) and over 500,000 alumni active in every region of the world, U of T's influence is felt in every area of human endeavour.

B.Sc. in Biology

McMaster University is a public research university located in Hamilton, Ontario, Canada. The main campus is located on 121 hectares (300 acres) of land near the residential neighbourhoods of Ainslie Wood and Westdale, adjacent to Hamilton's Royal Botanical Gardens. McMaster was controlled by the Baptist Convention of Ontario and Quebec until it became a privately chartered, publicly funded non-denominational institution in 1957. The university is co-educational, and has over 25,000 undergraduate and over 4,000 post-graduate students

Career History
President & Chief Executive Officer
Current

Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada.

Senior Vice President, Research & Development
2007 - 2016

Luminex Molecular Diagnostics, Inc. develops DNA based diagnostics tests and software solutions, which include genetic tests for disorders, drug metabolism and infectious diseases. The firm's products include P450-2D6, P450-2C9, P450-2C19, AJ panel and CFTR. The company was founded in March 2007 and is headquartered in Toronto, Canada.

Senior Vice President, Research & Development
2007 - 2016

Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX.

Boards & Committees
Member, Board of Directors
Current

Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jeremy Bridge-Cook. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jeremy Bridge-Cook's profile does not indicate a business or promotional relationship of any kind between RelSci and Jeremy Bridge-Cook.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/jeremy-bridge-cook-3207013
  • https://relationshipscience.com/person/jeremy-bridge-cook-3207013